Treatment and low-density lipoprotein cholesterol levels in patients with hypercholesterolaemia or mixed dyslipidaemia at high or very high cardiovascular risk: a population-based cross-sectional study in the Netherlands.

Autor: Heintjes EM; PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands., Anastassopoulou A; Market Access Europe, Daiichi Sankyo Europe GmbH, Munich, Germany., Kuiper J; PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands., Bilitou A; Market Access Europe, Daiichi Sankyo Europe GmbH, Munich, Germany., Beest FJAP; PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands., Herings RMC; PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands.; Pharmacoepidemiology & Health Care Optimization, Department of Epidemiology & Data Science, Amsterdam Public Health Research Institute, Amsterdam UMC (Location VUmc), Amsterdam, the Netherlands., Postma MJ; Department of Health Sciences, University Medical Center Groningen, Groningen, the Netherlands.; Department of Economics, Econometrics & Finance, Faculty of Economics & Business, University of Groningen, Groningen, the Netherlands., Jukema JW; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.; Netherlands Heart Institute, Utrecht, the Netherlands.

Publikováno v: Current medical research and opinion [Curr Med Res Opin] 2023 Jan; Vol. 39 (1), pp. 1-11. Date of Electronic Publication: 2022 Oct 14.

Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases.

Autor: Kruik-Kollöffel WJ; Department of Clinical Pharmacy, Ziekenhuisgroep Twente (Hospital Group Twente), Almelo and Hengelo, the Netherlands., van der Palen J; Medical School Twente, Medisch Spectrum Twente, Enschede, the Netherlands.; Department of Research Methodology, Measurement and Data Analysis, University of Twente, Enschede, the Netherlands., Doggen CJM; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands., van Maaren MC; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Kruik HJ; Department of Cardiology, Ziekenhuisgroep Twente (Hospital Group Twente), Almelo and Hengelo, the Netherlands., Heintjes EM; PHARMO Institute, Utrecht, the Netherlands., Movig KLL; Department of Clinical Pharmacy, Medisch Spectrum Twente, Enschede, the Netherlands., Linssen GCM; Department of Cardiology, Ziekenhuisgroep Twente (Hospital Group Twente), Almelo and Hengelo, the Netherlands.

Publikováno v: PloS one [PLoS One] 2020 Dec 22; Vol. 15 (12), pp. e0244231. Date of Electronic Publication: 2020 Dec 22 (Print Publication: 2020).

Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study.

Autor: van Houtum, William¹ (AUTHOR) whvanhoutum@xs4all.nl, Schrömbges, Patrick² (AUTHOR), Amadid, Hanan³ (AUTHOR), van Bon, Arianne C.⁴ (AUTHOR), Braae, Uffe C.³ (AUTHOR), Hoogstraten, Charlotte⁵ (AUTHOR), Herrings, Hans⁶ (AUTHOR)

Publikováno v: Diabetes Therapy. Aug2024, Vol. 15 Issue 8, p1749-1768. 20p.

Trends in mortality, cardiovascular complications, and risk factors in type 2 diabetes.

Autor: Heintjes EM; PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands., Houben E, Beekman-Hendriks WL, Lighaam E, Cremers SM, Penning-van Beest FJA, Stehouwer CDA, Herings RMC

Publikováno v: The Netherlands journal of medicine [Neth J Med] 2019 Dec; Vol. 77 (9), pp. 317-329.

PDB2 - Glycemic Control of Adult Type 2 Diabetes Mellitus Patients In The Netherlands: A Cross-Sectional Real World Database Study

Autor: Heintjes, EM, Overbeek, JA, Huisman, EL, van Diermen, A, Schoonen, M, Dinissen, C, Penning-van Beest, FJ, Herings, RM

Publikováno v: In Value in Health October-November 2017 20(9):A474-A474